POSEIDA THERAPEUTICS INC earnings per share and revenue

2RZ earnings per share for the last quarter are 0.19 EUR whereas the estimation was -0.37 EUR which accounts for 150.30% surprise. Company revenue for the same period amounts to 64.44 M EUR despite the estimated figure of 14.59 M EUR. Estimated earnings per share for the next quarter are -0.28 EUR, and revenue is expected to reach 28.98 M EUR. Also watch annual changes over time to get a bigger picture of 2RZ earnings per share and revenue dynamics.